Bph in the next millennium:a glimpse to the future


Play all audios:

ABSTRACT Benign prostatic hyperplasia (BPH) is a highly prevalent, age-related disease. As the world population continues to grow and life expectancy increases, the population of men


suffering from BPH will expand. A greater emphasis will be placed on quality of life. The BPH patient of the future will also have greater expectations regarding therapy, which will need to


be effective in a shorter period of time. New technologies for the treatment of BPH are anticipated. Already, robot-operated vaporisation of the prostate is being undertaken. With regard to


medical therapy, more selective and hence, more effective drugs are under development. With the identification of new α1-adrenoceptor subtypes, α-blocker therapy should target the prostate


more accurately. Gene-based therapies will have an important role in the future. It is envisaged that technology will exist whereby defective genes can be replaced and gene expression


controlled to overcome the disease process. Through pharmacogenomics, drugs will be tail-ored to the individual, which will, in turn, result in more economical use of medical therapy.


Similarly, the development of nanotechnology will allow site-specific delivery of drugs. Together, these advances will make the treatment of BPH even more effective in the new millennium.


Access through your institution Buy or subscribe This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to this


journal Receive 4 print issues and online access $259.00 per year only $64.75 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now


Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer


support SIMILAR CONTENT BEING VIEWED BY OTHERS EJACULATORY FUNCTION AFTER ROBOTIC WATERJET ABLATION FOR THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA: A SYSTEMATIC REVIEW Article Open access


14 May 2025 RELATIONSHIPS BETWEEN HOLMIUM LASER ENUCLEATION OF THE PROSTATE AND PROSTATE CANCER Article 23 November 2022 TWO-YEAR LONG-TERM FOLLOW-UP OF TREATMENT WITH THE OPTILUME BPH


CATHETER SYSTEM IN A RANDOMIZED CONTROLLED TRIAL FOR BENIGN PROSTATIC HYPERPLASIA (THE PINNACLE STUDY) Article Open access 29 April 2024 AUTHOR INFORMATION AUTHORS AND AFFILIATIONS *


Institute of Urology and Nephrology, University College London–Middlesex Hospital, London, UK F Gómez-Sancha Authors * F Gómez-Sancha View author publications You can also search for this


author inPubMed Google Scholar RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Gómez-Sancha, F. BPH in the next millennium:a glimpse to the future.


_Prostate Cancer Prostatic Dis_ 2 (Suppl 4), S21–S25 (1999). https://doi.org/10.1038/sj.pcan.4500370 Download citation * Published: 16 December 1999 * Issue Date: 01 December 1999 * DOI:


https://doi.org/10.1038/sj.pcan.4500370 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not


currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative KEYWORDS * benign prostatic hyperplasia * treatment *


pharmacogenomics * nanotechnology * α-blockers